China SXT Pharmaceuticals (SXTC) Loans and Notes Receivables (2018 - 2022)
China SXT Pharmaceuticals (SXTC) has 4 years of Loans and Notes Receivables data on record, last reported at $35509.0 in Q1 2022.
- For Q1 2022, Loans and Notes Receivables changed N/A year-over-year to $35509.0; the TTM value through Mar 2022 reached $35509.0, changed N/A, while the annual FY2022 figure was $35509.0, N/A changed from the prior year.
- Loans and Notes Receivables reached $35509.0 in Q1 2022 per SXTC's latest filing, up from $17744.0 in the prior quarter.
- Across five years, Loans and Notes Receivables topped out at $303379.0 in Q1 2018 and bottomed at $17744.0 in Q1 2020.
- Average Loans and Notes Receivables over 4 years is $109474.2, with a median of $58387.0 recorded in 2019.
- Peak YoY movement for Loans and Notes Receivables: plummeted 73.21% in 2019, then plummeted 78.17% in 2020.
- A 4-year view of Loans and Notes Receivables shows it stood at $303379.0 in 2018, then tumbled by 73.21% to $81265.0 in 2019, then tumbled by 78.17% to $17744.0 in 2020, then skyrocketed by 100.12% to $35509.0 in 2022.
- Per Business Quant database, its latest 3 readings for Loans and Notes Receivables were $35509.0 in Q1 2022, $17744.0 in Q1 2020, and $81265.0 in Q1 2019.